Lymphoscintigraphy in oncology: A rediscovered challenge

European Journal of Nuclear Medicine

Volumn 26, Issue SUPPL., 1999, Pages

  Valdés Olmos, Renato A ^a   Hoefnagel, Cornelis A ^a   Nieweg, Omgo E ^a   Jansen, Liesbeth ^a   Rutgers, Emiel J Th ^a   Borger, Jacques ^a   Horenblas, Simon ^a   Kroon, Bin B R ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Breast cancer; Lymphoscintigraphy; Melanoma; Oncology; Other malignancies

Indexed keywords

ANTIMONY; ANTIMONY TECHNETIUM SULFIDE TC 99M; RADIOPHARMACEUTICAL AGENT; SULFUR; TRACER;

BREAST CANCER; CANCER DIAGNOSIS; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; EDEMA; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MELANOMA; ONCOLOGY; PENIS CANCER; SUBCUTANEOUS DRUG ADMINISTRATION; VULVA CANCER;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MALE; MELANOMA;

EID: 0032905204     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050571     Document Type: Conference Paper

References (56)

1. Ege G. Internal mammary lymphoscintigraphy in breast carcinoma: a study of 1072 patients. Int J Radiat Oncol Biol Phys 1977; 2: 755-761.
2. Alasraki NP, Eshima D, Eshima LA, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperalive gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997; 27: 55-67.
3. Cabanas RM. An approach to the treatment of penile carcinoma. Cancer 1977; 39: 456-466.
4. Morton DL, Wen DR, Wong JH, Economus JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
5. Uren RF, Howman-Giles R, Thompson JF, Shaw HM, Quinn, O'Brien CJ, McCarthy WH. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Research 1994; 4: 395-399.
6. Kapteijn BC, Nieweg OE, Valdés Olmos RA, Liem IH, Baidjnath Panday RKL, Hoefnagel CA, Kroon BBR. Reproducibility of lymphoscintigraphy for lymphatic mapping in cutaneous melanoma. J Nucl Med 1996; 37: 972-975.
7. Kapteijn BC. Biopsy of the sentinel node in melanoma, penile carcinoma and breast carcinoma. Thesis, University of Amsterdam, 1997.
8. De Hullu JA, Doting E, Piers DA, Hollema H, Aalders JG, Schraffordt Koops H, Boonstra H, van der Zee AGJ. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998; 39: 1381-1385.
9. Uren RF, Howman-Giles RB. Thompson JF. Mammary lymphoscintigraphy in breast cancer. J Nucl Med 1995; 36: 1775-1780.
10. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, van Diest PJ, Teule GJJ. Impact of lymphoscintigraphy on sentinel-node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997; 38: 366-368.
11. Kapteijn BAE, Nieweg OE, Muller SH, Liem IH, Hoefnagel CA, Rutgers EJTh, Kroon BBR. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 1997; 38: 362-366.
12. Ege GN. Lymphoscintigraphy, techniques and application in the management of breast carcinoma. Semin Nucl Med 1983; 13: 26-34.
13. Bennet LR, Lago G. Cutaneous lymphoscintigraphy in malignant melanoma. Semin Nucl Med 1983; 13: 61-69.
14. Eberbach MA, Wahl RL, Argenta LC, Froelich J, Niederhuber JE. Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck and upper thorax. Surgery 1987; 102: 433-442.
15. Berger DH, Feig BW, Podoloff D, Norman J, Cruse CW, Reintgen DS, Ross MI. Lymphoscintigraphy as a predictor of lymphatic drainage from cutaneous melanoma. Ann Surg Oncol 1997; 4: 247-251.
16. Pijpers HJ, Collet CJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995; 22: 1238-1241.
17. Kelley MC, Ollila DW, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma. Semin Surg Oncol 1998; 14: 283-290, 1998.
18. Hoefnagel CA. Role of nuclear medicine in melanoma. Eur J Nucl Med 1998; 25: 1567-1574.
19. Kapteijn BA, Nieweg OE, Liem IH, Mooi WJ, Balm AJM, Muller SH, Peterse JL, Valdés Olmos RA, Hoefnagel CA, Kroon BBR. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997; 4: 156-160.
20. Mudun A, Murray DR, Herda SC, Eshima D, Shattuck LA, Vansant JP, Taylor AT, Alazraki NP. Early stage melanoma: lymphoscintigraphy, reproducibility of sentinel node detection and effectiveness of the intraoperative gamma probe. Radiology 1996; 199: 171-175.
21. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma: predicting draining node groups, defining lymphatic channels. J Nucl Med 1993; 34: 1435-1440.
22. Jansen L, Nieweg OE, Kapteijn BAE, Valdés Olmos RA, Hoefnagel CA, Kroon BBR. Accuracy of lymphoscintigraphy in indicating the number of sentinel lymph nodes in patients with melanoma. Proc World Fed Surg Oncol Soc and Soc Surg Oncol Meeting, San Diego 1998 (abstract).
23. Vidal-Sicart S, Piulachs J, Pons S, Castel T, Palou J, Herranz R, Setoain J. Detección del ganglio centinela mediante linfogammagrafía y sonda de rayos gamma intraoperatoria en pacientes con melanoma maligno. Rev Esp Med Nucl 1998; 17: 15-20.
24. Uren RF, Howman-Giles RB, Thompson JF. Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy for melanoma: incidence varies with primary tumor site. Ann Surg Oncol 1998; 5: 517-521.
25. Uren RF, Howman-Giles R, Thompson JF. Lymphatic drainage from the skin of the back to retroperitoneal and paravertebral lymph nodes in melanoma patients. Ann Surg Oncol 1998; 5: 384-387.
26. Hoefnagel CA, Bartelink H, Heidendal-Jeune M, Marcuse. Internal mammary chain lymphoscintigraphy for radiation therapy planning in breast carcinoma. J Eur Radiother 1982; 3: 35-42.
27. nd edition, Edinburgh London New York: Churchill Livingstone: 1998: 783-790.
28. Kaplan WD. Lymphoscintigraphy: importance to cancer detection and radiation treatment planning. In: Meyer JL, ed. The Lymphatic System and Cancer. Front Radiat Ther Oncol, Basel, Karger, 1994, 28: 25-36.
29. Vendrell-Torné, Setoain-Quinquer J, Doménech-Torné FM. Study of normal mammary lymphatic drainage using radioactive isotopes. J Nucl Med 1972; 13: 801-805.
30. Nieweg OE, Jansen I, Valdés Olmos RA, Rutgers EJTh, Peterse JL, Hoefnagel CA, Kroon BBR. Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med 1999, in press.
31. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-427.
32. Roumen RMH, Valkenburg JGM, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23: 495-502.
33. Reuhl T, Kaisers H, Markwardt J, Haensch W, Hohenberger P, Schlag PM. Axillaauraumung bei klinisch nodal-negativem mammakarzinoom. Kann die Indikation durch "sentinel node" Nachweis individualisiert werden? Dsich Med Wochenschr 1998; 123: 583-587.
34. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guide-lines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-283.
35. Van de Ent FWC, Kengen RAM, Van der Poll HAG, Hoofwijk AGM. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with a blue dye tracer. Eur J Surg Oncol 1999 (abstract).
36. Gill PG, Hall VE, Kirkwood I, Chatterton BE, Coventry B, Vernon-Roberts E. Lymphoscintigraphy for locating the sentinel lymph node in patients with breast cancer. Breast 1997; 6: 225 (abstract).
37. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349: 1864-1867.
38. Fajardo LF. Lymph nodes and cancer. A review. In: Meyer JL, ed. The lymphatic system and cancer. Front Radiat Ther Oncol, Basel, Karger. 1994; 28: 1-10.
39. Gabell P, Comet M, Bodin JP, Dupré A, Carpentier E, Bolla M, Swiercz P. La lymphoscintigraphie mammaire par injection intr-tumorale dan le bilan du cancer du sein. Nouv Presse Med 1981; 10: 3067-3070.
40. Serin D, Vinot Marin P, Reboul F, Robin M, Chevallier J. Intérêt de la lymphoscintigraphie mammaire dans la définition du staging axillaire des cancers du sein. Bull Cancer 1986; 73: 299-304.
41. Kapteijn BAE, Nieweg OE, Peterse JL, Rutgers EJTh Rutgers, Hart AAM, Van Dongen JA, Kroon BBR. Sequential lymphatic dissemination of breast cancer. Eur J Surg Oncol 1998; 24: 427-430.
42. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998; 339: 941-946.
43. McMasters KM, Giulano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, et al. Sentinel -lymph-node biopsy for breast cancer-not yet the standard care. N Engl J Med 1998; 339: 990-995.
44. Uren RF, Howman-Giles RB, Thompson JF. The value of preoperative lymphoscintigraphy in breast cancer treatment. Eur J Cancer 1998; 34: 203-204.
45. Bourgeois P, Nogaret JM, Veys I, Hertens D, Coibion M, Frühling J. Sentinel node biopsy. Eur J Nucl Med 1998; 25: 1588-1589.
46. Paganelli G, De Cicco C. Sentinel node biopsy. Reply to Bourgeois et al. Eur J Nucl Med 1998; 25: 1589-1590.
47. Koch WM, Choti MA, Civelek C, Eisele DW, Saunders JR. Gamma probe biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998; 124: 455-459.
48. Kaplan WD. Iliopelvic lymphoscintigraphy. Semin Nucl Med 1983; 13: 42-53.
49. Ege GN, Cummings BJ. Interstitial radiocolloid iliopelvic lymphoscintigraphy: technique, anatomy, and clinical application. Int J Rad Oncol Biol Phys 1980; 6: 1483-1490.
50. Horenblas S, Nuyten MJC, Hoefnagel CA, Moonen LMF, Delemarre JFM. Detection of lymph node invasion in prostatic carcinoma with ileopelvic lymphoscintigraphy. Br J Urol 1992; 69: 180-182.
51. Jonk A, Kroon BR, Mooi WJ, Hoefnagel CA. Contralateral inguinal lymph node metastasis in patients with melanoma of the lower extremities. Br J Surg 1989; 76: 1161-1162.
52. Hoefnagel CA, Jonk A, Kroon BB. Contralateral lymph node metastasis in patients with melanoma of the lower extremity: a lymphoscintigraphic explanation. J Nucl Med 1989; 30: 912 (abstract).
53. Perre CL, Hoefnagel CA, Kroon BBR, Zoetmulder FAN, Rutgers EJTh. Altered lymphatic drainage after lymphaadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg 1996; 83: 1258.
54. Rees WV, Robinson DS, Holmes EC, et al. Altered lymphatic drainage following lymphadenectomy. Cancer 1980; 45: 3045-3049.
55. Bloomer WD. Lymphoscintigraphy in gynecologic malignancies. Semin Nucl Med 1983; 13: 54-60.
56. Kroon BBR. Over het ontstaan en de chirurgische behandeling van maligne ascites. Thesis, University of Amsterdam. 1986.